期刊文献+

肌萎缩侧索硬化起病部位与通气功能障碍的关系

Association between site of onset and ventilation dysfunction in patients with amyotrophic lateral sclerosis
原文传递
导出
摘要 目的 采用回顾性研究的方法探讨中国肌萎缩侧索硬化(ALS)的起病部位与通气功能障碍的关系.方法 采集2009年1月至2013年9月北京大学第三医院神经内科诊治的344例散发性ALS(SALS)的临床病例,比较不同起病部位的患者之间用力肺活量(FVC)的差异.结果 在344例SALS患者中,球部起病组55例,FVC均值为84%±14%,FVC< 80%有24例(43.64%).上肢起病组200例,FVC均值为83%±17%,FVC< 80%有81例(40.50%).下肢起病组89例,FVC均值为88%±16%,FVC< 80%有25例(28.09%).上肢起病组的FVC均值显著低于下肢起病组(P<0.05),且发生FVC< 80%的比例显著高于下肢起病组(P<0.05).球部起病组的FVC均值略低于下肢起病组,发生FVC< 80%的比例高于下肢起病组,但差异无统计学意义.结论 与上肢起病的SALS相比,下肢起病的患者更少且更晚出现通气功能障碍,也更少及更晚需要应用无创正压通气(NIPPV)治疗. Objective To study the association between site of onset and ventilation dysfunction in Chinese patients with amyotrophic lateral sclerosis.Methods The clinical data of 344 patients with sporadic amyotrophic lateral sclerosis (SALS) in Department of Neurology of Peking University Third Hospital from January 2009 to September 2013 were retrospectively reviewed.The differences of Forced Vital Capacity (FVC) between groups with distinct site of onset were analyzed.Results There were 55, 200 and 89 patients in the group with bulbar, upper limb and lower limb onset, respectively.The values of FVC were 84%±14%, 83% ± 17% and 88% ± 16%, and the cases of FVC 〈 80% were 24 (43.64%), 81 (40.50%) and 25 (28.09%) in each group.The mean value of FVC was significantly lower and the frequency of FVC 〈 80% statistically higher in the group with upper limb onset in comparison with the group with lower limb onset.The mean value of FVC was lower and the frequency of FVC 〈 80% higher in the group with bulbar onset than in the group with lower limb onset.However, the differences were not significant between the two groups.Conclusions Compared with SALS with upper limb onset, ventilation function disorder may occur less and later in patients with lower limb onset, who may also require noninvasive positive pressure ventilation (NIPPV) less and later.
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第43期3496-3500,共5页 National Medical Journal of China
基金 国家自然科学基金重点项目(81030019) 教育部博士点基金(20100001110084)
关键词 肌萎缩侧索硬化 散发性 用力肺活量 Amyotrophic lateral sclerosis Sporadic Forced Vital Capacity
  • 相关文献

参考文献21

  • 1MitchellJD, BorasioGD. Amyotrophic lateral sclerosis[J].Lancet, 2007, 369(9578):2031-2041.
  • 2AndersenPM, BorasioGD, DenglerR, et al. Good practice in the management of amyotrophic lateral sclerosis:clinical guidelines. An evidence-based review with good practice points. EALSC Working Group[J].Amyotroph Lateral Scler, 2007, 8(4):195-213.
  • 3StamblerN, CharatanM, CedarbaumJM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group[J].Neurology, 1998, 50(1):66-72.
  • 4CzaplinskiA, YenAA, AppelSH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population[J].J Neurol Neurosurg Psychiatry, 2006, 77(3):390-392.
  • 5刘小璇,樊东升,张俊.肌萎缩侧索硬化患者106例生存分析[J].中华神经科杂志,2009,42(6):402-405. 被引量:12
  • 6MillerRG, JacksonCE, KasarskisEJ, et al. Practice parameter update:the care of the patient with amyotrophic lateral sclerosis:drug, nutritional, and respiratory therapies (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology, 2009, 73(15):1218-1226.
  • 7CarratùP, SpicuzzaL, CassanoA, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency[J].Orphanet J Rare Dis, 2009, 4:10.
  • 8LogroscinoG, TraynorBJ, HardimanO, et al. Incidence of amyotrophic lateral sclerosis in Europe[J].J Neurol Neurosurg Psychiatry, 2010, 81(4):385-390.
  • 9ChiòA, LogroscinoG, HardimanO, et al. Prognostic factors in ALS:A critical review[J].Amyotroph Lateral Scler, 2009, 10(5-6):310-323.
  • 10Standardization of Spirometry, 1994 Update. American Thoracic Society[J].Am J Respir Crit Care Med, 1995, 152(3):1107-1136.

二级参考文献14

  • 1康德瑄,樊东升.胸锁乳突肌肌电图在鉴别肌萎缩侧索硬化与颈椎病性脊髓病的研究[J].中国神经精神疾病杂志,1994,20(1):5-7. 被引量:47
  • 2Millul A,Beghi E,Logroscino G,et al.Survival of patients with amyotrophic lateral sclerosis in a population-based registry.Neuroepidemiology,2005,25:114-119.
  • 3Chio A.Mora G.Leone M.et al.Early symptom progression rate is related to ALS outcome:a prospective population-based study.Neurology,2002,59:99-103.
  • 4del Aguila MA,Longstreth WT Jr,McGuire V,et al.Prognosis in amyotrophic lateral sclerosis:a population-based study.Neurology,2003,60:813-819.
  • 5Magnus T,Beck M,Gioss R,et al.Disease progression in amyotrophic lateral sclerosis:predictors of survival.Muscle Nerve,2002,25:709-714.
  • 6Brooks BR,Miller RG,Swash M,et al.El Escorial revisited:revised criteria for the diagnosis of amyotrophic lateral sclerosis.Amyotroph Lateral Scler Other Motor Neuron Disord,2000,1:293-299.
  • 7The Amyotrophic Lateral Sclerosis Functional Rating Scale.Assessement of activities of daily living in patients with amyotrophic lateral sclerosis.The ALS CNTF Treatment Study (ACTs) Phase Ⅰ-Ⅱ Study Group.Arch Neurol,1996,53:141-147.
  • 8Argyriou AA,Polychronopoules P,Papapetropoulos S,et al.Clinical and epidemiological features of motor neuron disease in scuth-westem Greece.Acta Neurol Scand,2005,111:108-113.
  • 9Mandrioli J,Faglioni P,Merelli E,et al.The epidemiology of ALS in Modena,Italy.Neurology,2003,60:683-689.
  • 10Haverkamp LJ,Appel V,Appol SH.Natural history of amyotrophic lateral sclerosis in a database population.Validation of a scoring system and a model for survival prediction.Brain,1995,118 Pt 3:707-719.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部